138 related articles for article (PubMed ID: 1806028)
1. Hematopoietic growth factors in breast cancer--overview.
Osborne CK
Breast Cancer Res Treat; 1991 Dec; 20 Suppl():S1-2. PubMed ID: 1806028
[No Abstract] [Full Text] [Related]
2. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
Demetri GD
Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782
[TBL] [Abstract][Full Text] [Related]
3. Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Hayes S; Howell A
Eur J Cancer; 1997 Nov; 33(13):2171-82. PubMed ID: 9470803
[No Abstract] [Full Text] [Related]
4. [Relation dose efficacy in chemotherapy: the example of breast cancer].
Chevallier B; Perrocheau G
Bull Cancer; 1995; 82 Suppl 1():9s-15s. PubMed ID: 7626858
[TBL] [Abstract][Full Text] [Related]
5. High dose chemotherapy with haemopoietic support for breast cancer.
Steward WP
Eur J Cancer; 1995; 31A Suppl 7():S21-4. PubMed ID: 8562187
[No Abstract] [Full Text] [Related]
6. Chemotherapy of small cell lung cancer.
Hansen HH; Kristjansen PE
Eur J Cancer; 1991; 27(3):342-9. PubMed ID: 1851028
[No Abstract] [Full Text] [Related]
7. The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed.
D'Hondt L; Emmons RV; André M; Guillaume T; Feyens AM; Canon JL; Humblet Y; Longueville J; Symann M
Leuk Lymphoma; 1999 Jun; 34(1-2):105-9. PubMed ID: 10350337
[TBL] [Abstract][Full Text] [Related]
8. [Clinical use of hematopoietic growth factors in treatment of bone marrow failure].
Robak T; Krykowski E
Pol Arch Med Wewn; 1994 Jul; 92(1):1-8. PubMed ID: 7971472
[No Abstract] [Full Text] [Related]
9. Intermittent G-CSF to maintain dose intensity of chemotherapy for Hodgkin's disease.
Clarke K; Grigg A
Leuk Lymphoma; 1995 Nov; 19(5-6):521-2. PubMed ID: 8590858
[No Abstract] [Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Ayash LJ; Elias A; Wheeler C; Tepler I; Schwartz G; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(4):507-11. PubMed ID: 7916250
[TBL] [Abstract][Full Text] [Related]
11. Dose intensity as a therapeutic strategy in breast cancer.
Osborne CK
Breast Cancer Res Treat; 1991 Dec; 20 Suppl():S11-4. PubMed ID: 1687202
[TBL] [Abstract][Full Text] [Related]
12. The clinical role of growth factors in the treatment of breast cancer.
Fetscher S; Mertelsmann R
Biomed Pharmacother; 1998; 52(3):101-8. PubMed ID: 9755802
[TBL] [Abstract][Full Text] [Related]
13. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma.
Canellos GP
Ann Oncol; 1994; 5 Suppl 2():121-2. PubMed ID: 8204512
[No Abstract] [Full Text] [Related]
14. Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis.
Glück S
Can J Oncol; 1995 Dec; 5 Suppl 1():58-62. PubMed ID: 8853527
[TBL] [Abstract][Full Text] [Related]
15. Dose optimisation and dose intensification in malignant lymphoma.
Linch DC
Eur J Cancer; 1994; 30A(1):122-5. PubMed ID: 8142153
[No Abstract] [Full Text] [Related]
16. Optimal delivery of dose in cancer chemotherapy with the support of haematopoietic growth factors.
Trillet-Lenoir V; Arpin D; Brune J
Eur J Cancer; 1993; 29A Suppl 5():S14-6. PubMed ID: 8260260
[TBL] [Abstract][Full Text] [Related]
17. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort.
Du XL; Lairson DR; Begley CE; Fang S
J Clin Oncol; 2005 Dec; 23(34):8620-8. PubMed ID: 16314624
[TBL] [Abstract][Full Text] [Related]
18. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
O'Shaughnessy JA; Cowan KH; Nienhuis AW; McDonagh KT; Sorrentino BP; Dunbar CE; Chiang Y; Wilson W; Goldspiel B; Kohler D
Hum Gene Ther; 1994 Jul; 5(7):891-911. PubMed ID: 7526902
[TBL] [Abstract][Full Text] [Related]
19. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
Hast R; Eriksson M; Jakovleva K
Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
[No Abstract] [Full Text] [Related]
20. Multiple myeloma: a tailored therapy for elderly patients.
Pileri A; Palumbo A; Boccadoro M
Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
